Literature DB >> 25489256

Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec.

A R Spence1, A Alobaid2, P Drouin3, P Goggin4, L Gilbert5, D Provencher3, P Tousignant6, J A Hanley7, E L Franco8.   

Abstract

BACKGROUND: Cervical cancer (cca) is largely a preventable disease if women receive regular screening, which allows for the detection and treatment of preinvasive lesions before they become invasive. Having been inadequately screened is a common finding among women who develop cca. Our primary objective was to determine the Pap screening histories of women diagnosed with cca in Montreal, Quebec. Secondary objectives were to determine the characteristics of women at greatest risk of cca and to characterize the level of physician contact those women had before developing cca.
METHODS: The Invasive Cervical Cancer Study, a population-based case-control study, consisted of Greater Montreal residents diagnosed with histologically confirmed cca between 1998 and 2004. Respondents to the 2003 Canadian Community Health Survey and a sample of women without cca obtained from Quebec medical billing records served as controls.
RESULTS: During the period of interest, 568 women were diagnosed with cca. Immigrants and women speaking neither French nor English were at greatest risk of cca. Most of the women in the case group had been screened at least once during their lifetime (84.8%-90.4%), but they were less likely to have been screened within 3 years of diagnosis. Having received care from a family physician or a medical specialist other than a gynecologist within the 5 years before diagnosis was associated with a greater risk of cca development.
CONCLUSIONS: Our findings provide evidence of the need for an organized population-based screening program. They also underscore the need for provider education to prevent missed opportunities for cca screening when at-risk women seek medical attention.

Entities:  

Keywords:  Cervical cancer; Papanicolaou test; screening

Year:  2014        PMID: 25489256      PMCID: PMC4257112          DOI: 10.3747/co.21.2056

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  30 in total

1.  An investigation of the effects of social desirability on the validity of self-reports of cancer screening behaviors.

Authors:  Timothy P Johnson; Diane P O'Rourke; Jane E Burris; Richard B Warnecke
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

Review 2.  Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model.

Authors:  Crista E Johnson; Katherine E Mues; Stephanie L Mayne; Ava N Kiblawi
Journal:  J Low Genit Tract Dis       Date:  2008-07       Impact factor: 1.925

3.  Socioeconomic position and stage of cervical cancer in Danish women diagnosed 2005 to 2009.

Authors:  Else Ibfelt; Susanne K Kjær; Christoffer Johansen; Claus Høgdall; Marianne Steding-Jessen; Kirsten Frederiksen; Birgitte Lidegaard Frederiksen; Merete Osler; Susanne Oksbjerg Dalton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-20       Impact factor: 4.254

4.  Low rates of cervical cancer screening among urban immigrants: a population-based study in Ontario, Canada.

Authors:  Aisha K Lofters; Rahim Moineddin; Stephen W Hwang; Richard H Glazier
Journal:  Med Care       Date:  2010-07       Impact factor: 2.983

5.  Cervical smear histories of Maori women developing invasive cervical cancer.

Authors:  K Ratima; C Paul; D C Skegg
Journal:  N Z Med J       Date:  1993-12-08

6.  An epidemiologic study of Pap screening histories in women with invasive carcinomas of the uterine cervix.

Authors:  P C Nasca; N Ellish; T A Caputo; K Saboda; B Metzger
Journal:  N Y State J Med       Date:  1991-04

7.  Physician self-report of comfort and skill in providing preventive care to patients of the opposite sex.

Authors:  N Lurie; K Margolis; P G McGovern; P Mink
Journal:  Arch Fam Med       Date:  1998 Mar-Apr

8.  The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.

Authors:  J Hsia; E Kemper; C Kiefe; J Zapka; S Sofaer; M Pettinger; D Bowen; M Limacher; L Lillington; E Mason
Journal:  Prev Med       Date:  2000-09       Impact factor: 4.018

9.  Pap recency: modeling women's characteristics and their patterns of medical care use.

Authors:  J Camirand; L Potvin; F Béland
Journal:  Prev Med       Date:  1995-05       Impact factor: 4.018

10.  Immigrant women and cervical cancer screening uptake: a multilevel analysis.

Authors:  Kelly J Woltman; K Bruce Newbold
Journal:  Can J Public Health       Date:  2007 Nov-Dec
View more
  4 in total

1.  Factors associated with cervical cancer screening participation among immigrants of Russian, Somali and Kurdish origin: a population-based study in Finland.

Authors:  Esther E Idehen; Tellervo Korhonen; Anu Castaneda; Teppo Juntunen; Mari Kangasniemi; Anna-Maija Pietilä; Päivikki Koponen
Journal:  BMC Womens Health       Date:  2017-03-11       Impact factor: 2.809

2.  Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general Finnish population.

Authors:  Esther E Idehen; Päivikki Koponen; Tommi Härkänen; Mari Kangasniemi; Anna-Maija Pietilä; Tellervo Korhonen
Journal:  Int J Equity Health       Date:  2018-05-04

3.  Cervical Cancer Screening Participation among Women of Russian, Somali, and Kurdish Origin Compared with the General Finnish Population: A Register-Based Study.

Authors:  Esther E Idehen; Anni Virtanen; Eero Lilja; Tomi-Pekka Tuomainen; Tellervo Korhonen; Päivikki Koponen
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 3.390

Review 4.  Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.

Authors:  Patrícia Marques; Mariana Nunes; Maria da Luz Antunes; Bruno Heleno; Sónia Dias
Journal:  Int J Equity Health       Date:  2020-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.